Psoriasis
CRITERIA FOR EVALUATION
- Male or Female
- Age 12 – 75 years
- At least 2% of body surface area affected
- Moderate or severe symptoms
Alopecia Areata – Two Studies
CRITERIA FOR EVALUATION
- Pediactric Study: Ages 6 – 18 years
- Adult Study: Ages 19 years or older
- Both studies require participants to have suffered at least 50% hair loss or greater
Vitiligo
CRITERIA FOR EVALUATION
- Male or Female
- Age 19 years or older
- Clinical diagnosis of non-segmental vitiligo for at least 3 months
- Present on face and body
Abdominal Fat
CRITERIA FOR EVALUATION
- Male or Female
- Age 19 – 64 years
- Have a BMI between 18.5-30
- Weight that remains stable with very little fluctuation
Hidradenitis Suppurativa
CRITERIA FOR EVALUATION
- Male or Female
- Age 19 years or older
- Have moderate to severe symptoms or lesions of Hidradenitis Suppurativa for greater than 12 months
- More than 5 lesions in two different anatomical locations
Acne
CRITERIA FOR EVALUATION
- Male or Female
- Age 12 – 45 years
- Have moderate to severe facial acne
- Have a BMI between 18.5-40
Atopic Dermatitis
CRITERIA FOR EVALUATION
- Male or Female
- Age 19 years or older
- Have mild, moderate or severe Atopic Dermatitis
- Atopic Dermatitis covering at least 4% of body area
- Chronic Atopic Dermatits present at least 1 year
Scalp Psoriasis
CRITERIA FOR EVALUATION
- Male or Female
- Age 12 years or older
- Scalp psoriasis covering at least 1% of the scalp area
Common Wart
CRITERIA FOR EVALUATION
- Male or Female
- Age 12 years or older
- Have common warts present
Mid-face Volume Loss
CRITERIA FOR EVALUATION
- Male or Female
- Age 22 years or older
- Have midface volume deficiency
UNDER THE DIRECTION OF JOEL SCHLESSINGER, MD
More clinical trials are coming soon at Schlessinger MD Research Center
Thank you for your interest in our Clinical Trials division at Schlessinger MD. More clinical trials are underway and will be posted here in the coming weeks.
